Drug trial aims to block inflammation, stop cancer before it starts in Ex-Smokers
Prevention
Ongoing
This study is testing whether a drug called canakinumab can help prevent lung cancer in former heavy smokers. Researchers are giving the drug to 41 participants to see if it reduces inflammation in the lungs, which is linked to cancer development. The main goal is to see if block…
Phase: PHASE2 • Sponsor: Peter Shields • Aim: Prevention
Last updated Mar 31, 2026 12:11 UTC